Claudia A. Lebedinsky
Claudia A. Lebedinsky publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Hematology, on topics such as Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments and Lung Cancer Treatments and Mutations.
- World rank
- #1,811,830 of 7,710,434 ranked researchers
- Rank in Spain
- #38,428 of 204,306
- Works
- 77
- Citations
- 2k
- Citations per work
- 26.6
What does Claudia A. Lebedinsky research?
Claudia A. Lebedinsky's work is mostly in Medicine (50%), Biochemistry, Genetics and Molecular Biology (14%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3849.7%
- Medicine3849.7%
- Everything else2835.8%
- Life Sciences1114.5%
- 1Pulmonary and Respiratory Medicine18% of their works
- 2Oncology12% of their works
- 3Hematology11% of their works
- 4Genetics9% of their works
- 5Molecular Biology8% of their works
- 6Cancer Research7% of their works
Research topics
Which keywords describe Claudia A. Lebedinsky's research?
The keywords of their largest research topics: Chemotherapy, Clinical Trials, Targeted Therapy, JAK2 Mutation, Myelofibrosis, Metastasis, ALK Inhibitors and BCR-ABL.
- Tumorigenesis
- KRAS Mutations
- Mutational Signatures
- Ovarian Cancer
- Soft Tissue Sarcoma
- Imatinib
- BCR-ABL
- Metastasis
- JAK2 Mutation
- Clinical Trials
- Chemotherapy
- Targeted Therapy
- Myelofibrosis
- ALK Inhibitors
- EGFR Mutations
- Osteosarcoma
- Genomic Analysis
- Cancer Genomics
- Cetuximab
- Pim Oncogenes
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Chemotherapy313 topics
- Clinical Trials242 topics
- Targeted Therapy232 topics
- JAK2 Mutation191 topic
- Myelofibrosis191 topic
- Metastasis182 topics
- ALK Inhibitors131 topic
- BCR-ABL131 topic
- EGFR Mutations131 topic
- Imatinib131 topic
- Osteosarcoma131 topic
- Soft Tissue Sarcoma131 topic
- Genomic Analysis111 topic
- Ovarian Cancer111 topic
- Cancer Genomics101 topic
- Mutational Signatures101 topic
- Cetuximab71 topic
- KRAS Mutations71 topic
- Pim Oncogenes71 topic
- Tumorigenesis71 topic
Where does Claudia A. Lebedinsky work?
Claudia A. Lebedinsky's main affiliation in the publication record is PharmaMar (Spain), Spain.
How many publications and citations does Claudia A. Lebedinsky have?
OpenAlex counts 77 works and 2,046 citations for Claudia A. Lebedinsky, an h-index of 17, ranking #1,811,830 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Claudia A. Lebedinsky. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.